← FDA Drug Approvals (Drugs@FDA)

DALFAMPRIDINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MICRO LABS · Approved 2019-03-11

Drug application

FDA Application #

ANDA210158

Application type

Abbreviated New Drug Application (Generic)

Brand name

DALFAMPRIDINE

Generic name

DALFAMPRIDINE

Active ingredients

DALFAMPRIDINE

Dosage form

TABLET, EXTENDED RELEASE

Route

ORAL

Marketing status

Prescription

Sponsor

MICRO LABS

Manufacturer

Micro Labs Limited

First approval

2019-03-11

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown